U.S. Online Retail and Ecommerce Stock News

NYSE:ESE
NYSE:ESEMachinery

3 Grid Stocks Riding Data Center Power Demand

Electricity demand is climbing as data centers, AI workloads, and electrification plans put extra pressure on already stretched grids. At the same time, supply risks in key energy chokepoints are pushing governments and utilities to focus more on resilient, flexible power systems. That mix of higher demand and energy security concerns is pulling attention toward companies exposed to grid equipment, transmission, metering, substation technology, and energy storage. This article walks through 3...
NasdaqGS:AXTI
NasdaqGS:AXTISemiconductor

AXT (AXTI) Lands Nanjing Casela Supply Deal For AI And Optics Growth

AXT (NasdaqGS:AXTI) announced a supply deal with China's Nanjing Casela for indium phosphide substrates. The agreement focuses on serving demand in AI and advanced optics applications. Wedbush Securities views the arrangement as reducing export risk for AXT. AXT is a specialty materials company focused on compound semiconductor substrates used in areas such as data communications, sensing and optics. The new agreement with Nanjing Casela gives the company additional access to the China...
NYSE:GETY
NYSE:GETYInteractive Media and Services

Getty Images Holdings (GETY) Is Up 38.2% After OpenAI Display Pact With Licensed Image Library

In June 2026, Getty Images announced a multi-year display agreement with OpenAI that will integrate its licensed visual content libraries into ChatGPT’s search and discovery features, enriching on-platform visual responses with authenticated imagery. This move places Getty Images’ rights-cleared library at the heart of one of the world’s most widely used AI interfaces, highlighting how licensed content can underpin more trustworthy visual AI experiences. We’ll now examine how this OpenAI...
NasdaqGS:ZM
NasdaqGS:ZMSoftware

Zoom (ZM) Launches New AI Tools For Customer Service And Telehealth

Zoom Communications (NasdaqGS:ZM) has rolled out new AI-powered tools for its Virtual Agent platform. The company has also enabled integration with Canary Ambient on the Zoom App Marketplace. These updates expand Zoom's reach in healthcare and customer service automation. Zoom Communications is pushing further into AI driven business tools as it looks beyond its core video conferencing roots. The stock currently trades at $86.445, with the share price up 13.1% over the past year and 3.8%...
NYSE:VRT
NYSE:VRTElectrical

Vertiv (VRT) Stock After 160% One-Year Gain Is The Recent Rally Justified

If you are wondering whether Vertiv Holdings Co at around US$318 per share still offers value after a strong run, this article breaks down what the current price might be implying. The stock has risen 6.2% over the past week, is down 2.8% over the past month, and shows returns of 81.3% year to date and 160.5% over the past year, with an especially large gain over three years. Recent coverage of Vertiv has focused on the company's role in critical infrastructure for data centers and power...
NYSE:FLUT
NYSE:FLUTHospitality

Flutter Entertainment (NYSE:FLUT) Plans To Leave London For A Sole NYSE Listing

Flutter Entertainment plans to delist from the London Stock Exchange and move to a sole NYSE listing under ticker NYSE:FLUT. The company outlined the intention following a review of trading activity and regulatory considerations. The decision marks a structural shift in how Flutter Entertainment engages with public markets and its shareholder base. Flutter Entertainment is set to concentrate its listing in the US market, with NYSE:FLUT becoming its primary trading venue. The move comes at a...
NYSE:AIT
NYSE:AITTrade Distributors

Applied Industrial Technologies (AIT) Stock After 137% Three-Year Run Is Further Upside Justified

If you are wondering whether Applied Industrial Technologies is priced attractively after a strong run, the starting point is to separate recent share price excitement from what the underlying valuation actually suggests. The stock last closed at US$330.90, with returns of 2.0% over the past week, 7.7% over the past month, 27.5% year to date and 41.9% over the last year, alongside a very large 3 year gain of 137.3% and a 5 year return of 287.5%. These returns have kept Applied Industrial...
NYSE:PRIM
NYSE:PRIMConstruction

Primoris (PRIM) Cuts 2026 Outlook As COO Exit Adds To Renewables Trouble

Primoris Services (NYSE:PRIM) sharply cut its 2026 profit and renewables revenue guidance. The company reported persistent cost overruns and project delays in its Renewables segment. Primoris Services announced the sudden departure of its Chief Operating Officer. Multiple law firms have launched investigations following a steep share price drop. Primoris Services (NYSE:PRIM) is under pressure after a sharp reset to its 2026 earnings outlook and renewables revenue guidance, combined with the...
NasdaqGS:QURE
NasdaqGS:QUREBiotechs

uniQure (QURE) Reports Early AMT 260 Data With Seizure Reduction In Epilepsy

uniQure (NasdaqGS:QURE) reported positive initial data from its Phase I/IIa trial of AMT-260 for refractory mesial temporal lobe epilepsy. Several patients in the initial low dose cohort experienced meaningful seizure reduction, with an encouraging safety profile. This is the first clinical efficacy and safety readout for AMT-260, expanding uniQure's pipeline beyond Huntington's disease. uniQure, trading at $49.04, is drawing fresh attention as AMT-260 moves from concept to early clinical...
NYSE:BSX
NYSE:BSXMedical Equipment

Boston Scientific (BSX) Faces Flat Watchman Revenue As Doctors Combine Heart Procedures

Boston Scientific’s Watchman heart device is increasingly being implanted during combined cardiac procedures instead of as a standalone treatment. This shift in medical practice has reduced standalone Watchman procedure volumes and is expected to keep revenue for the product line roughly flat through Q3 2026. The change reflects how doctors are rethinking procedure planning, with implications for Boston Scientific’s growth mix and product planning. For investors watching Boston Scientific...
NasdaqGS:TOWN
NasdaqGS:TOWNBanks

TowneBank (TOWN) Joins A Key Bank Index, Is The Stock Fully Priced?

Index inclusion puts TowneBank in focus TowneBank (TOWN) has been added to the S&P Banks Select Industry Index, an event that can shift how institutional investors view and access the stock. This index inclusion may influence trading activity, liquidity, and how TowneBank fits into diversified banking portfolios. See our latest analysis for TowneBank. TowneBank’s recent index inclusion comes on the back of steady share price momentum, with a 90 day share price return of 6.76% and a 1 year...
NYSE:TGT
NYSE:TGTConsumer Retailing

Target (TGT) Stock After 43% Yearly Gain Is There Still Upside Potential

If you are wondering whether Target stock still offers value after its recent run, this article walks through what the current price might be implying about the company. At a last close of US$134.11, Target has posted returns of 0.5% over the past week, 6.8% over the past month, 33.4% year to date and 43.5% over the past year, which naturally raises questions about how much upside or downside may be left. Recent commentary around Target has focused on how the stock reflects changing...
NYSE:ZETA
NYSE:ZETASoftware

Zeta Global (ZETA) Teams Up With Palantir To Build Enterprise AI For Marketing

Zeta Global Holdings (NYSE:ZETA) has entered into a partnership with Palantir Technologies to build a unified enterprise AI infrastructure layer for marketing. The collaboration centers on rearchitecting Zeta’s Data Cloud on Palantir’s Foundry platform and integrating Zeta’s Athena AI to support real-time marketing decisions. Both companies point to the potential for this integration to support new revenue streams tied to large enterprise marketing use cases. Zeta Global Holdings comes into...
NYSE:AB
NYSE:ABCapital Markets

Is AllianceBernstein Holding (AB) Fairly Valued Following Its Recent Share Price Weakness?

AllianceBernstein Holding (AB) stock has drawn attention after recent price moves, with the shares last closing at US$35.78. Investors are weighing this level against the company’s mixed growth profile and current valuation signals. See our latest analysis for AllianceBernstein Holding. Recent trading puts AllianceBernstein Holding’s share price under gentle pressure, with the stock down over the past week and month, while the 3 year total shareholder return remains positive. This suggests...
NYSE:NEM
NYSE:NEMMetals and Mining

Newmont (NEM) Stock After Recent Pullback Is The Rally Losing Steam Or Not

If you are wondering whether Newmont at US$97.84 is still offering value after a strong run, the key question is how its current price lines up with what the business might reasonably be worth. The stock has pulled back recently, declining 9.8% over the past week and 9.1% over the past month, although it is still up 70.2% over the past year and 80.7% over five years, with a 3.3% decline year to date and a 146.2% return over three years. Recent market attention on Newmont has been shaped by...
NasdaqGS:NTAP
NasdaqGS:NTAPTech

NetApp (NTAP) Stock Weighed Against AI Growth Hopes And DCF Fair Value Estimate

How NetApp’s Valuation Fits Into a Long Term View Before weighing any valuation method, it helps to place NetApp in a broader investing context so that the numbers you are about to see fit into a bigger picture. Instead of thinking about valuation as a single answer, consider it as a set of lenses that can highlight different strengths and weaknesses of the stock. Why Valuation Matters For NetApp Stock Valuation is ultimately about what you are paying today compared with what the business may...
NasdaqGM:IOVA
NasdaqGM:IOVABiotechs

Iovance Biotherapeutics (IOVA) Wins Australia Approval For Amtagvi In Melanoma

Iovance Biotherapeutics (NasdaqGM: IOVA) received conditional approval in Australia for Amtagvi, its T-cell therapy for advanced melanoma. The Therapeutic Goods Administration decision marks the third marketing authorization for Amtagvi after the US and Canada. Amtagvi becomes the first approved solid tumor T-cell therapy in the Australian market and is supported by an Australian treatment center. Iovance Biotherapeutics focuses on cell therapies that use a patient's own T cells to target...
NasdaqGS:SNPS
NasdaqGS:SNPSSoftware

Synopsys (SNPS) Stock Weighs Rich P/E Against DCF Fair Value After Recent Pullback

If you are wondering whether Synopsys stock is priced attractively or already baking in high expectations, this valuation breakdown is designed to give you a clear and structured view. Recently, the share price closed at US$461.50, with a 2.9% gain over the past week, but a decline of 12.1% over the last month and 3.9% so far this year, including a 3.6% decline over the past 12 months. These mixed returns have kept Synopsys in focus as investors weigh long term prospects against current...
NasdaqGS:RMBS
NasdaqGS:RMBSSemiconductor

3 Crypto Stocks Tied To AI Infrastructure Worth A Closer Look

Crypto and blockchain stocks sit at the crossroads of finance and technology at a time when inflation trends, interest rate decisions and energy prices are pulling markets in different directions. With mixed signals across major economies and central banks reassessing policy paths, many investors are looking for exposure to themes that are tied to long term structural change rather than short term data noise. This Top Cryptocurrency and Blockchain Stocks screener filters the broader market to...